Interwest Venture Management Co
- SEC CIK
- 0001697720
- Latest filing
- Oct 20, 2023
Holdings in Q1 2022
Holdings as of Mar 31, 2022, filed Apr 13, 2022. Long positions only; changes compare share counts with Q4 2021.
- Positions
- 9
- 0 vs. Q4 2021
- Portfolio value
- $261.8M
- +$92.6M (+54.7%) vs. Q4 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BRZEBraze, Inc. | Stock | 3,394,219 | $140.8M | 53.8% | +3,394,219 | New | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 3,234,911 | $67.4M | 25.7% | 00.0% | Unchanged | History |
| GKOSGLAUKOS Corp | COM | 350,264 | $20.3M | 7.7% | 00.0% | Unchanged | History |
| REALTheRealReal, Inc. | COM | 2,354,080 | $17.1M | 6.5% | 00.0% | Unchanged | History |
| SERASera Prognostics, Inc. | CLASS A COM | 2,416,241 | $9.16M | 3.5% | 00.0% | Unchanged | History |
| EIGREiger BioPharmaceuticals, Inc. | COM | 560,990 | $4.66M | 1.8% | −203,928−26.7% | Reduced | History |
| AGTCApplied Genetic Technologies Corp | COM | 1,404,515 | $1.50M | 0.6% | 00.0% | Unchanged | History |
| VEROVenus Concept Inc. | COM | 658,657 | $942.0K | 0.4% | 00.0% | Unchanged | History |
| DAREDare Bioscience, Inc. | COM | 62,065 | $92.0K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q4 2021 (1)
Positions held at the end of Q4 2021 that are gone from this filing.